Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Splanchnic III
NCT04575428Phase 2Completed
- Sponsor
- Duke University
- Start
- Feb 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic heart failure (CHF), sponsored by Duke University. Started Feb 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT04575428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575428.